HOME >> MEDICINE >> NEWS
7th Annual AIDS Science Day at Yale April 22

The Center for Interdisciplinary Research on AIDS (CIRA) will host the 7th Annual AIDS Science Day on Friday, April 22 at the Omni New Haven Hotel at Yale, 155 Temple St.

CIRAaffiliated scientists from Yale, the Hispanic Health Council and The Institute for Community Research, will present their findings to scientific and community members. The event is free and open to the public, but registration is required for lunch. Attendees will have the opportunity to learn about the latest research in HIV/AIDS prevention, treatment and care. It will also offer an opportunity to improve existing HIV/AIDS programs and to build coalitions to support improved services. Another goal is to increase collaboration between the community and the university. The event is sponsored by CIRA.

Events include panel presentations, a poster session, 18 community booths and a keynote address by George Ayala, director of the Institute for Gay Men's Health. Ayala's talk is titled "Holding Open Space: Retooling and ReImagining HIV Prevention Research for Gay and Bisexual Men."

Also on display throughout the conference will be a traveling photo exhibit titled "Giving Women Power Over AIDS," sponsored by the Global Campaign for Microbicides. The exhibit will travel to Philadelphia, Seattle, Sacramento, San Francisco, Los Angles, Atlanta, Washington, D.C., Baltimore, Chicago, Hartford, New York City and Boston.

The day's agenda includes:

8:15 to 9 a.m.: Poster Set Up and Registration

9 a.m. to 12 noon: Welcoming Remarks & Start of Program

  • "Where the Boys Are: HIV Risk and Men's Health"
  • "Trainspotting: Implications of Drug Use Preparation and Treatment for HIV Risk and Prevention"
  • "The Color Purple: HIV Risk and Prevention Among Women and Children"

12 noon to 1:30 p.m.:

  • Lunch (PreRegistrants Only)
  • Community Booths and Poster Sessions
<
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
12-Apr-2005


Page: 1 2

Related medicine news :

1. AIUM hosts Third Annual Ultrasound Practice Forum
2. Pfizer Onocology press briefing scheduled during ASCO 2007 Annual Meeting
3. News from American Psychiatric Association 2007 Annual Meeting
4. Interventional cardiologists assemble in Orlando, Fla., for SCAI Annual Scientific Sessions
5. SNMs 54th Annual Meeting speakers address state of molecular imaging/nuclear medicine technologies
6. Annual meeting of the National Academy of Sciences
7. Nancy Brinker and Lance Armstrong honored with Centennial Medals at the AACR 2007 Annual Meeting
8. 2007 ARVO Annual Meeting draws spotlight on aging eye
9. Annual study finds top hospitals have 28 percent lower mortality rate
10. AIUM to host Annual Convention
11. American Society of Biomechanics Annual Meeting Sept. 6-9

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Annual AIDS Science Day Yale April

(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: